Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory

European Journal of Pharmacology

Volumn 395, Issue 2, 2000, Pages 149-156

  Hiramatsu, Masayuki ^a   Inoue, Kaori ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Opioid receptor; Naloxone benzoylhydrazone; Nocistatin; Passive avoidance; Spontaneous alternation

Indexed keywords

NALOXONE BENZOYLHYDRAZONE; NOCICEPTIN; NOCISTATIN; NORBINALTORPHIMINE; SCOPOLAMINE;

AMNESIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; LEARNING; MALE; MAZE TEST; MOTOR ACTIVITY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; AVOIDANCE LEARNING; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; LEARNING DISORDERS; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NEUROPROTECTIVE AGENTS; OPIOID PEPTIDES; PSYCHOMOTOR PERFORMANCE; RATS; SCOPOLAMINE;

EID: 0034725105     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00162-X     Document Type: Article

References (36)

1. Anton B., Fein J., To T., Li X., Silberstein L., Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J. Comp. Neurol. 368:1996;229-251.
2. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
3. Colombo P.J., Martinez J.L. Jr., Bennett E.L., Rosenzweig M.R. Kappa opioid receptor activity modulates memory for peck-avoidance training in the 2-day-old chick. Psychopharmacology. 108:1992;235-240.
4. Faden A.I. Dynorphin increases extracellular levels of excitatory amino acid in the brain through a non-opioid mechanism. J. Neurosci. 12:1992;425-429.
5. Florin S., Suaudeau C., Meunier J.C., Costentin J. Nociceptin stimulates locomotion and exploratory behaviour in mice. Eur. J. Pharmacol. 317:1996;9-13.
6. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
7. Hiramatsu M., Inoue K. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice. Br. J. Pharmacol. 127:1999;655-660.
8. Hiramatsu M., Inoue K. Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. Eur. J. Pharmacol. 367:1999;151-155.
9. Hiramatsu M., Inoue K. Improvement by low doses of nociceptin/orphanin FQ on scopolamine-induced impairment of learning and/or memory in mice. 29th Neurosci. Abstr. 25:1999;1121.
10. Hiramatsu M., Inoue K., Kameyama T. Dynorphin A-(1-13) and (2-13) improve β-amyloid peptide-induced amnesia in mice. NeuroReport. 11:2000;1-5.
11. 1-dynorphin analogs reverse impairment of learning and/or memory in non-opioid receptor mediated mechanism in mice. 28th Neurosci. Abstr. 24:1998;684.
12. Hiramatsu M., Murasawa H., Mori H., Kameyama T. Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A-(1-13), an endogenous κ-opioid agonist. Br. J. Pharmacol. 123:1998;920-926.
13. Hiramatsu M., Mori H., Murasawa H., Kameyama T. Dynorphin A-(1-13) improves galanin-induced impairment of memory accompanied by blockage of reductions in acetylcholine release in rats. Br. J. Pharmacol. 118:1996;255-260.
14. Hiramatsu M., Sasaki M., Kameyama T. Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task. Eur. J. Pharmacol. 282:1995;185-191.
15. Hiramatsu M., Sasaki M., Nabeshima T., Kameyama T. Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice. Pharmacol. Biochem. Behav. 56:1997;73-79.
16. Inoue K., Hiramatsu M., Kameyama T. Dynorphin A-(2-13) reverses impairment of learning and memory in non-opioid receptor-mediated mechanisms in mice. Jpn. J. Pharmacol. 79:1999;. Suppl., 55P.
17. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice. Eur. J. Pharmacol. 236:1993;341-345.
18. Itoh K., Konya H., Takai E., Masuda H., Nagai K. Modification of acetylcholine release by nociceptin in conscious rat striatum. Brain Res. 845:1999;242-245.
19. + currents in hippocampal CA1 neurons by both ORL-1 and opiate receptor mechanisms. J. Neurophysiol. 82:1999;1776-1785.
20. Mamiya T., Noda Y., Nishi M., Takeshima H., Nabeshima T. Nociceptin system plays a role in the memory retention: involvement of nalxone benzoylhydrazone binding sites. NeuroReport. 10:1999;1171-1175.
21. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., Noda T., Takahashi T., Sugimoto T., Nabeshima T., Takeshima H. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature. 394:1998;577-581.
22. Mathis J.P., Ryan-Moro J., Chang A., Hom J.S.H., Scheinberg D.A., Pasternak G.W. Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain. Biochem. Biophys. Res. Commun. 230:1997;462-465.
23. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol. 340:1997;1-15.
24. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
25. Newhouse A. Cholinergic drug studies in dementia and depression. Adv. Exp. Med. Biol. 282:1990;65-76.
26. Noda Y., Mamiya T., Nabeshima T., Nishi M., Higashioka M., Takeshima H. Loss of antinociception induced by naloxone benzoylhydrazone in nociceptin receptor-knockout mice. J. Biol. Chem. 273:1998;18047-18051.
27. Nothacker H.P., Reinscheid R.K., Mansour A., Henningsen R.A., Ardati A., Monsma F.J. Jr., Watson S.J., Civelli O. Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8677-8682.
28. Okuda-Ashitaka E., Minami T., Tachibana S., Yoshihara Y., Nishiuchi Y., Kimura T., Ito S. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature. 392:1998;286-289.
29. Pan Y.X., Cheng J., Xu J., Rossi G., Jacobson E., Ryan-Moro J., Brooks A.I., Dean G.E., Standifer K.M., Pasternak G.W. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor. Mol. Pharmacol. 47:1995;1180-1188.
30. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J. Jr., Civelli O. Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science. 270:1995;792-794.
31. Sandin J., Georgieva J., Schött P.A., Ögren S.O., Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur. J. Neurosci. 9:1997;194-197.
32. Sarter M., Bodewitz G., Stephens D.N. Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and antagonist β-carboline. Psychopharmacology. 94:1988;491-495.
33. 35S]guanylyl-5′-O-(gamma-thio)-triphosphate binding in guinea pig brain. J. Comp. Neurol. 386:1997;562-572.
34. 35S]GTPγS binding in rat brain. NeuroReport. 7:1996;729-733.
35. Yu T.P., Fein J., Phan T., Evans C.J., Xie C.W. Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus. 7:1997;88-94.
36. Zhang S., Yu L. Identification of dynorphins as endogenous ligands for an opioid receptor-like orphan receptor. J. Biol. Chem. 270:1995;22772-22776.